Chewy Shares Climb on Upbeat Outlook, but It's Not Too Late to Buy the Stock

Chewy guided fiscal 2026 revenue of $13.6B–$13.75B (+8%–9%) and adjusted EBITDA of $900M–$930M+ (+20%–29%), targeting adj. EBITDA margins of 6.6%–6.8% (~+100bps vs FY25). Fiscal Q4 revenue was $3.26B (+0.5% y/y) in line with expectations and adjusted EPS was $0.27 (missed by $0.01); normalized 13-week sales were +8.1%, active customers +4% to 21.3M, autoship sales accounted for 84% of revenue, gross margin +90bps to 29.4%, and adjusted EBITDA rose 30.4% to $162.3M. Management cites private-brand penetration, AI adoption, and a new Houston fulfillment center as margin drivers; the stock trades at ~17x forward P/E (14x next year), implying potential upside.

Analysis

Chewy’s durable subscription cohort is more than a revenue stabilizer — it is a lever that re‑shapes who captures margin in the pet channel. As management ramps proprietary assortment and monetizes ad inventory, brand suppliers and marketplace sellers face a two‑front squeeze: lower per‑unit shelf economics from private label and higher CAC from platform ad bidding. That dynamic favors firms with captive repeat demand and scale logistics, and makes regional fulfillment density (Houston ramp) a direct driver of unit economics, not just capacity.

The immediate risk set is executional rather than cyclical: integrating niche acquisitions, proving ad monetization at scale, and converting AI pilots into recurring cost savings. Near‑term equity sensitivity will be to quarterly cadence on engagement/ARPU and early KPIs from the new FC; medium term, the equity will reprice on visible FCF conversion and sustained margin progression. A true downside shock would be an aggressive competitive response (promotional subsidies by a deep‑pocket marketplace) or a persistent pullback in discretionary pet spend.

Consensus appears too anchored to category cyclicality and is underweight operating leverage that comes from concentrated repeat demand plus higher‑margin private labels and ads. That said, the rerating path is binary: investors will demand repeatable, multi‑quarter evidence of ad growth and acquisition economics before underwriting a sustained multiple expansion. Positioning should therefore be catalyst‑aware and calibrated between owning the story outright and buying optionality around the next 2–4 quarterly proof points.

Key Decisions for Investors

• Buy CHWY equity (core long) sized as 1–2% of fund NAV with a 6–12 month horizon. Trim on any guidance miss or if platform ad RPMs decelerate for two consecutive quarters. Target asymmetric upside of ~30–40% vs stop loss at ~15% to protect against short‑term demand shocks.
• Purchase CHWY 9–15 month at‑the‑money LEAP calls (allocate 20–30% of the equity notional) to capture rerating if margins and ad monetization continue to show sequential improvement; max loss = premium, potential levered upside if re‑rating occurs.
• Pair trade: long CHWY / short AMZN (or long CHWY / short broad e‑commerce retail ETF) for 6–12 months to isolate subscription‑driven margin upside vs marketplace discounting risk. Size the short to neutralize market beta and let relative comp drive returns.
• Hedge/alpha: buy NVDA Jan‑2027 calls (small size, ~10–15% of CHWY notional) to express upside from faster AI adoption lowering SG&A per order; consider a tactical short in INTC if you view accelerated GPU displacement as likely — keep that hedge size modest and event‑driven.